KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Hims & Hers Health (HIMS) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to 2.65%.

  • Hims & Hers Health's EBITDA Margin fell 1627.00% to 2.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.08%, marking a year-over-year decrease of 210.00%. This contributed to the annual value of 8.52% for FY2024, which is 1121.00% up from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's EBITDA Margin is 2.65%, which was down 66.80% from 7.98% recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBITDA Margin registered a high of 18.92% during Q3 2024, and its lowest value of -98.38% during Q1 2021.
  • Over the past 3 years, Hims & Hers Health's median EBITDA Margin value was 3.99% (recorded in 2024), while the average stood at 3.64%.
  • As far as peak fluctuations go, Hims & Hers Health's EBITDA Margin tumbled by 7,817bps in 2021, and later skyrocketed by 8,215bps in 2022.
  • Over the past 5 years, Hims & Hers Health's EBITDA Margin (Quarterly) stood at -36.89% in 2021, then skyrocketed by 3,048bps to -6.41% in 2022, then spiked by 692bps to 0.51% in 2023, then surged by 479bps to 5.29% in 2024, then slumped by 1,627bps to 2.65% in 2025.
  • Its last three reported values are 2.65% in Q3 2025, 7.98% for Q2 2025, and 8.47% during Q1 2025.